Real-world lymphoma cohort in an HIV-endemic setting: cohort design, epidemiological features and impact of implementing novel classification standards
Authors:
- Lillian F. AnderaLALillian F. Andera
- Dharshnee R. ChettyDCDharshnee R. Chetty
- Zainab MohamedZMZainab Mohamed
- Diana OelofseDODiana Oelofse
- Jenna BaileyJBJenna Bailey
- Karryn BrownKBKarryn Brown
- Katherine AntelKAKatherine Antel
- Kudakwashe SimbaKSKudakwashe Simba
- Gerdien KritzingerGKGerdien Kritzinger
- Sumaiya CassimSCSumaiya Cassim
- Amsha RamburanARAmsha Ramburan
Open Access
- 2 April 2026
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Abstract
Background: Lymphoma real-world observational data and accurate diagnostic systems are lacking in low-resource HIV-endemic settings. We established a new lymphoma registry to generate internationally comparable, clinically validated data, with up-to-date disease classification. We also describe our findings on aggressive B-cell lymphoma. Methods: The descriptive retrospective cohort included patients ≥ 13 years of age newly diagnosed with lymphoma from 2005 to 2020. Patients were enrolled at a single site in a registry with hierarchical groupings to capture, interrogate, and subtype lymphoma diagnoses. These were standardised on the most recent version of the World Health Organisation Classification of Haematolymphoid Tumours (WHO-HAEM5) and correlated with the novel International Consensus Classification of mature lymphoid neoplasms (ICC). Differences due to nomenclature and diagnostic category were annotated. Results: The cohort consisted of 2354 incident lymphoma cases; 1891 (80.3%) non-Hodgkin lymphoma and 463 (19.7%) Hodgkin lymphoma (HL). Twenty-one lymphoma NOS cases were excluded due to inadequate specimen for standardised subclassification. Overall reclassification according to WHO-HAEM5 was 25.8% ( n = 608). Notable nomenclature differences between WHO-HAEM5 and ICC included 44 (1.9%) transformations of indolent B-cell lymphomas; also 857 (36.4%) lymphoid proliferations and lymphomas associated with immune deficiency/dysregulation due to HIV (33.1%) and EBV (31.8%). EBV-association was highest among HL cases, of which 77 (50.3%) were HIV reactive. Conclusion: We report here the impact of adopting international lymphoma classification standards in an HIV-endemic setting. Our findings highlight the persistent prevalence of large B-cell lymphoma, raise concern around inadequate HIV suppression as a potential ongoing driver of disease in our setting, and provide further evidence for EBV-associated HL as a distinct subtype.Keywords
All Related Versions
Funding Information
- National Institutes of Health (DW TW010345)
- National Institutes of Health (DW TW010345)
- National Institutes of Health (DW TW010345)
- National Institutes of Health (DW TW010345)
- National Institutes of Health (DW TW010345)
- National Institutes of Health (DW TW010345)
- National Institutes of Health (DW TW010345)
- National Institutes of Health (DW TW010345)
- National Institutes of Health (DW TW010345)
- National Institutes of Health (DW TW010345)
- Cancer Research Initiative, Faculty of Health Sciences, University of Cape Town
- Cancer Association of South Africa
This publication has 56 references indexed in Scilit:
- Hodgkin lymphoma: the role of EBV plasma viral load testing in an HIV-endemic settingClinical and Experimental Medicine, 2024
- The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomesAmerican Journal of Hematology, 2024
- Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK’s Haematological Malignancy Research NetworkCancer Epidemiology, 2023
- Global patterns of non‐Hodgkin lymphoma in 2020International Journal of Cancer, 2022
- Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approachAmerican Journal of Hematology, 2022
- In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomesAnnals of Hematology, 2020
- Incidence of haematological malignancies, Eastern Cape Province; South Africa, 2004–2013Cancer Epidemiology, 2018
- Lymphoma and Pathology in Sub-Saharan AfricaClinics In Laboratory Medicine, 2018
- Analysis of referral appropriateness in the Western Cape, South Africa, and implications for resource allocationAfrican Journal of Emergency Medicine, 2012
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009